Improved efficacy to cytotoxic agents chemotherapy after immune checkpoint inhibitors exposure in metastatic gastric cancer

被引：0
|
作者：
Sagawa, Tamotsu
Sato, Yasushi
Hamaguchi, Kyoko
Hirakawa, Masahiro
Nagashima, Hiroyuki
Waga, Eriko
Fujikawa, Koshi
Takahashi, Yasuo
机构：
[1] Natl Hosp Org Hokkaido Canc Ctr, Div Gastroenterol, Sapporo, Hokkaido, Japan
[2] Tokushima Univ, Grad Sch Biomed Sci, Dept Gastroenterol & Oncol, Tokushima, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
297
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Application of immune checkpoint inhibitors in immunotherapy for gastric cancer
    Wu, Yi-Xiang
    Zhou, Xiao-Yu
    Wang, Jian-Qi
    Chen, Gao-Min
    Chen, Jin-Xu
    Wang, Rong-Chang
    Huang, Jiong-Qiang
    Chen, Jing-Song
    IMMUNOTHERAPY, 2023, 15 (02) : 101 - 115
  • [22] Immune-Driven Pathogenesis of Neurotoxicity after Exposure of Cancer Patients to Immune Checkpoint Inhibitors
    Vilarino, Noelia
    Bruna, Jordi
    Kalofonou, Foteini
    Anastopoulou, Garifallia G.
    Argyriou, Andreas A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (16) : 1 - 12
  • [23] Effect of immune checkpoint inhibitors in metastatic gastric cancer: A real-world evidence study
    Puccetti, F.
    Mazza, E.
    Hernandez-Ibarburu, G.
    Rusconi, F.
    Liscia, N.
    Barbieri, L. A.
    Treppiedi, E.
    Cossu, A.
    Rosati, R.
    Elmore, U.
    ANNALS OF ONCOLOGY, 2023, 34 : S880 - S880
  • [24] Re: Response Rate to Chemotherapy after Immune Checkpoint Inhibition in Metastatic Urothelial Cancer
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2019, 202 (04): : 658 - 659
  • [25] Immune profiling of malignant effusion from metastatic gastric cancer patients as a predictive biomarker for immune checkpoint inhibitors
    Kwon, Woo Sun
    Lim, So Jung
    Lee, Won Suk
    Jo, Eunji
    Kim, Hyun-jeong
    Lee, Kyung Hee
    Chung, Hyun Cheol
    Rha, Sun Young
    CANCER RESEARCH, 2016, 76
  • [26] EFFICACY AND SAFETY OF SALVAGE CHEMOTHERAPY FOLLOWING EXPOSURE TO IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Makio, Takechi
    Hara, S.
    Hosoi, K.
    Kinishita, Y.
    Min, K.
    RESPIROLOGY, 2017, 22 : 114 - 115
  • [27] Treatments after Immune Checkpoint Inhibitors in Patients with dMMR/MSI Metastatic Colorectal Cancer
    Bui, Quang Loc
    Mas, Leo
    Hollebecque, Antoine
    Tougeron, David
    de la Fouchardiere, Christelle
    Pudlarz, Thomas
    Alouani, Emily
    Guimbaud, Rosine
    Taieb, Julien
    Andre, Thierry
    Colle, Raphael
    Cohen, Romain
    CANCERS, 2022, 14 (02)
  • [28] Immune checkpoint inhibitors modulate the cytotoxic effect of chemotherapy in lung adenocarcinoma cells
    Saar, Marika
    Lavogina, Darja
    Lust, Helen
    Tamm, Hannes
    Jaal, Jana
    ONCOLOGY LETTERS, 2023, 25 (04)
  • [29] The efficacy of immune checkpoint inhibitors in patients with cancer with pseudoprogression
    Lyadova, Marina
    Fedorinov, Denis
    Pardabekova, Olesya
    Nosova, Margarita
    Tuleiko, Veronika
    Lyadov, Vladimir
    Kuzmina, Evgenia
    Antonova, Tatiana
    Lyadov, Konstantin
    Galkin, Vsevolod
    Poddubnaya, Irina
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [30] Efficacy of immune checkpoint inhibitors and age in cancer patients
    Huang, Xuan-zhang
    Gao, Peng
    Song, Yong-xi
    Sun, Jing-xu
    Chen, Xiao-wan
    Zhao, Jun-hua
    Wang, Zhen-ning
    IMMUNOTHERAPY, 2020, 12 (08) : 587 - 603
12345